A detailed history of State Of Wyoming transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, State Of Wyoming holds 363 shares of MEDP stock, worth $121,056. This represents 0.03% of its overall portfolio holdings.

Number of Shares
363
Previous 392 7.4%
Holding current value
$121,056
Previous $158,000 5.7%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $10,788 - $12,305
-29 Reduced 7.4%
363 $149,000
Q1 2024

May 13, 2024

SELL
$284.87 - $413.31 $7,121 - $10,332
-25 Reduced 6.0%
392 $158,000
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $15,471 - $21,262
-68 Reduced 14.02%
417 $127,000
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $55,921 - $67,319
239 Added 97.15%
485 $117,000
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $11,984 - $15,370
64 Added 35.16%
246 $59,000
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $871 - $1,197
5 Added 2.82%
182 $34,000
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $14,081 - $20,844
-92 Reduced 34.2%
177 $37,000
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $870 - $1,094
-6 Reduced 2.18%
269 $42,000
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $154,677 - $199,619
-1,188 Reduced 81.2%
275 $41,000
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $138 - $214
1 Added 0.07%
1,463 $240,000
Q4 2021

Feb 11, 2022

SELL
$182.74 - $227.9 $8,954 - $11,167
-49 Reduced 3.24%
1,462 $318,000
Q3 2021

Feb 11, 2022

BUY
$170.18 - $198.21 $26,548 - $30,920
156 Added 11.51%
1,511 $286,000
Q2 2021

Feb 11, 2022

BUY
$158.62 - $194.3 $214,454 - $262,693
1,352 Added 45066.67%
1,355 $239,000
Q1 2021

Feb 08, 2022

BUY
$132.02 - $168.26 $396 - $504
3 New
3 $0

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.